Milestone Pharmaceuticals Announces Data Presented at ESC Congress 2026 on the Impact of Paroxysmal Supraventricular Tachycardia (PSVT) on Patients’ Daily Lives and Quality of Life Between Episodes
Globe Newswire•27/08/2026•08:00 ET
0
Whiz Insights
Get started
Create a free account to read the full story.